OSMCX | OSMYX | OSMCX / OSMYX | |
Total Expense Ratio | 2.13 | 1.13 | 188% |
Annual Report Gross Expense Ratio | 2.13 | 1.13 | 188% |
Fund Existence | 28 years | 20 years | - |
Gain YTD | 18.185 | 18.882 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.98B | 3.98B | 100% |
Annual Yield % from dividends | 0.47 | 1.47 | 32% |
Returns for 1 year | 1.40 | 3.81 | 37% |
Returns for 3 years | 6.47 | 11.54 | 56% |
Returns for 5 years | -17.37 | -9.60 | 181% |
Returns for 10 years | 6.31 | 23.66 | 27% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AHSZX | 18.89 | 0.02 | +0.11% |
Alger Health Sciences Z | |||
RMYCX | 9.66 | 0.01 | +0.10% |
Russell Inv Multi-Strategy Income C | |||
PQIRX | 26.60 | N/A | N/A |
Victory Pioneer Equity Income R | |||
RGICX | 43.49 | -0.19 | -0.43% |
American Funds Intl Gr and Inc R3 | |||
RIVDX | 19.37 | -0.15 | -0.77% |
American Funds International Vntg R-2 |